China’s tech regulation has continued to heat up as the nation’s regulatory body is now targeting payment systems. We explain the move and position it in the context of the country’s growing wave of antitrust action. Meanwhile, AstraZeneca is looking to break out across the Atlantic as it prepares to file its vaccine for US approval. Plus, the latest round goes to Amazon in the legal fight over a $10 billion United States defense cloud computing contract.
